The impact of access to addiction specialist on attitudes, beliefs and hospital-based opioid use disorder related care: A survey of hospitalist physicians

References

• Ahmad FR, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. 2020. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm Perhaps I should have listed this as a governmental document?
   Google Scholar
• Administration SAaMHS. Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health. Rockville, Maryland: Center for Behavioral Health Statistics and Quality SAaMHSA; 2018. (HHS Publication No. SMA 17-5068, NSDUH Series H-53).
   Google Scholar
• Unick GJ, Rosenblum D, Mars S, Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993–2009. PLOS One. 2013;8(2):e54496.
   PubMed Web of Science ®Google Scholar
• Ronan MV, Herzig SJ. Hospitalizations related to opioid abuse/dependence and associated serious infections increased sharply, 2002–12. Health Affairs. 2016;35(5):832–837.
   PubMed Web of Science ®Google Scholar
• Abuse S. Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63, Full Document. Substance Abuse and Mental Health Services Administration Rockville, MD; 2018.
   Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;(3):1–29. https://doi.org/10.1002/14651858.CD002209.pub2.
   Google Scholar
• Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.
   PubMed Web of Science ®Google Scholar
• Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137–145.
   PubMed Web of Science ®Google Scholar
• Hser YI, Saxon AJ, Huang D, et al. Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. Addiction. 2014;109(1):79–87.
   PubMed Web of Science ®Google Scholar
• Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346(jan30 5):f174–f174.
   PubMedGoogle Scholar
• Wheeler E, Jones TS, Gilbert MK, Davidson PJ. Opioid overdose prevention programs providing naloxone to laypersons - United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(23):631–635.
   PubMed Web of Science ®Google Scholar
• Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice. Subst Abus. 2015;36(2):240–253.
   PubMed Web of Science ®Google Scholar
• Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med. 2015;9(5):358–367.
   PubMed Web of Science ®Google Scholar
• Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49.
   PubMed Web of Science ®Google Scholar
• ASoA M. Public Policy Statement on the Use of Naloxone for the Prevention of OpioidOverdose Deaths. Chevy Chase, MD: American Society of Addiction Medicine; 2010, revised 2014, revised 2016. https://www.asam.org/docs/default-source/public-policy-statements/use-of-naloxone-for-the-prevention-of-opioid-overdose-deaths-final.pdf
   Google Scholar
• Administration SAaMHS. SAMHSA Opioid Overdose Prevention Toolkit. Rockville, MD: Substance Abuse and Mental Health Services Administration within the Department of Health and Human Services; 2018. https://store.samhsa.gov/product/Opioid-Overdose-Prevention-Toolkit/SMA18-4742
   Google Scholar
• Rhee TG, Rosenheck RA. Use of drug treatment services among adults with opioid use disorder: rates, patterns, and correlates. Psychiatr Serv. 2019;70(11):992–999.
   PubMed Web of Science ®Google Scholar
• Frazier W, Cochran G, Lo-Ciganic W-H, et al. Medication-assisted treatment and opioid use before and after overdose in pennsylvania medicaid. JAMA. 2017;318(8):750–752.
   PubMed Web of Science ®Google Scholar
• Andrilla CHA, Moore TE, Patterson DG, Larson EH. Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: a 5-year update. J Rural Health. 2019;35(1):108–112.
   PubMed Web of Science ®Google Scholar
• Mojtabai R, Mauro C, Wall MM, Barry CL, Olfson M. Medication Treatment for opioid use disorders in substance use treatment facilities. Health Affairs. 2019;38(1):14–23.
   PubMed Web of Science ®Google Scholar
• Rosenthal ES, Karchmer AW, Theisen-Toupal J, Castillo RA, Rowley CF. Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis. Am J Med. 2016;129(5):481–485.
   PubMed Web of Science ®Google Scholar
• Englander H, Weimer M, Solotaroff R, et al. Planning and designing the Improving Addiction Care Team (IMPACT) for hospitalized adults with substance use disorder. J Hosp Med. 2017;12(5):339–342.
   PubMed Web of Science ®Google Scholar
• Trowbridge P, Weinstein ZM, Kerensky T, et al. Addiction consultation services. Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017;79:1–5.
   PubMed Web of Science ®Google Scholar
• Wakeman SE, Metlay JP, Chang Y, Herman GE, Rigotti NA. Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity. J Gen Intern Med. 2017;32(8):909–916.
   PubMed Web of Science ®Google Scholar
• Weinstein ZM, Wakeman SE, Nolan S. Inpatient addiction consult service: expertise for hospitalized patients with complex addiction problems. Med Clin North Am. 2018;102(4):587–601.
   PubMed Web of Science ®Google Scholar
• Priest KC, McCarty D. Role of the hospital in the 21st century opioid overdose epidemic: the addiction medicine consult service. J Addict Med. 2019;13(2):104–112.
   PubMed Web of Science ®Google Scholar
• Theisen-Toupal J, Ronan MV, Moore A, Rosenthal ES. Inpatient management of opioid use disorder: a review for hospitalists. J Hosp Med. 2017;12(5):369–374.
   PubMed Web of Science ®Google Scholar
• Justice USDo. Title 21 Code of Federal Regulations. §1306.07 Administering or dispensing of narcotic drugs. 2005. https://www.deadiversion.usdoj.gov/21cfr/cfr/1306/1306_07.htm.
   Google Scholar
• Administration SAaMHS. Buprenorphine Waiver Management. 2018. https://www.samhsa.gov/programs-campaigns/medication-assisted-treatment/training-materials-resources/buprenorphine-waiver. Accessed December 13, 2018.
   Google Scholar
• Wachter RM, Goldman L. Zero to 50,000—the 20th anniversary of the hospitalist. N Engl J Med. 2016;375(11):1009–1011.
   PubMed Web of Science ®Google Scholar
• Wakeman SE, Pham-Kanter G, Donelan K. Attitudes, practices, and preparedness to care for patients with substance use disorder: results from a survey of general internists. Subst Abus. 2016;37(4):635–641.
   PubMed Web of Science ®Google Scholar
• Wakeman SE, Baggett MV, Pham-Kanter G, Campbell EG. Internal medicine residents’ training in substance use disorders: a survey of the quality of instruction and residents’ self-perceived preparedness to diagnose and treat addiction. Subst Abus. 2013;34(4):363–370.
   PubMed Web of Science ®Google Scholar
• Blackstock OJ, Moore BA, Berkenblit GV, et al. A cross-sectional online survey of HIV pre-exposure prophylaxis adoption among primary care physicians. J Gen Intern Med. 2017;32(1):62–70.
   PubMed Web of Science ®Google Scholar
• Behar E, Rowe C, Santos G-M, et al. Acceptability of naloxone co-prescription among primary care providers treating patients on long-term opioid therapy for pain. J Gen Intern Med. 2017;32(3):291–295.
   PubMed Web of Science ®Google Scholar
• Bruneau J, Ahamad K, Goyer M-È, et al. Management of opioid use disorders: a national clinical practice guideline. CMAJ. 2018;190(9):E247–E257.
   PubMed Web of Science ®Google Scholar
• van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1–2):23–35.
   PubMed Web of Science ®Google Scholar
• Wakeman SE, Kanter GP, Donelan K. Institutional substance use disorder intervention improves general internist preparedness, attitudes, and clinical practice. J Addict Med. 2017;11(4):308–314.
   PubMed Web of Science ®Google Scholar
• Hutchinson E, Catlin M, Andrilla CH, Baldwin LM, Rosenblatt RA. Barriers to primary care physicians prescribing buprenorphine. Ann Fam Med. 2014;12(2):128–133.
   PubMed Web of Science ®Google Scholar
• Kissin W, McLeod C, Sonnefeld J, Stanton A. Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence. J Add Dis. 2006;25(4):91–103.
   PubMed Web of Science ®Google Scholar
• Andrilla CHA, Coulthard C, Larson EH. Barriers rural physicians face prescribing buprenorphine for opioid use disorder. Ann Fam Med. 2017;15(4):359–362.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377–381.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208.
   PubMed Web of Science ®Google Scholar
• Kaucher KA, Acquisto NM, Broderick KB. Emergency department naloxone rescue kit dispensing and patient follow-up. Am J Emerg Med. 2018;36(8):1503–1504.
   PubMed Web of Science ®Google Scholar
• Dwyer K, Walley AY, Langlois BK, et al. Opioid education and nasal naloxone rescue kits in the emergency department. WestJEM. 2015;16(3):381–384.
   Google Scholar
• Behar E, Bagnulo R, Coffin PO. Acceptability and feasibility of naloxone prescribing in primary care settings: a systematic review. Prev Med. 2018;114:79–87.
   PubMed Web of Science ®Google Scholar
• Liebschutz JM, Crooks D, Herman D, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1369–1376.
   PubMed Web of Science ®Google Scholar
• D’Onofrio G, Chawarski MC, O’Connor PG, et al. Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention. J Gen Intern Med. 2017;32(6):660–666.
   PubMed Web of Science ®Google Scholar
• D’Onofrio G, O’Connor PG, Pantalon MV, et al. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636–1644.
   PubMed Web of Science ®Google Scholar
• Busch S, Hawk K, Fiellin D, et al. Health service use in a randomized clinical trial comparing three methods of emergency department interventions for opioid dependence. Drug Alcohol Depend. 2015;156:e32.
   Google Scholar
• Busch SH, Fiellin DA, Chawarski MC, et al. Cost-effectiveness of emergency department-initiated treatment for opioid dependence. Addiction. 2017;112(11):2002–2010.
   PubMed Web of Science ®Google Scholar
• Wen H, Borders TF, Cummings JR. Trends in buprenorphine prescribing by physician specialty. Health Aff. 2019;38(1):24–28.
   PubMed Web of Science ®Google Scholar
• Stein BD, Gordon AJ, Dick AW, et al. Supply of buprenorphine waivered physicians: the influence of state policies. J Subst Abuse Treat. 2015;48(1):104–111.
   PubMed Web of Science ®Google Scholar
• Englander H, Priest KC, Snyder H, Martin M, Calcaterra S, Gregg J. A call to action: hospitalists’ role in addressing substance use disorder. J Hosp Med. 2020;14(Volume 15, Issue 03):184–1e4.
   Google Scholar
• Bohnert AS, Bonar EE, Cunningham R, et al. A pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose. Drug Alcohol Depend. 2016;163:40–47.
   PubMed Web of Science ®Google Scholar
• Coffin PO, Santos GM, Matheson T, et al. Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial. PLOS One. 2017;12(10):e0183354.
   PubMed Web of Science ®Google Scholar
• Wagner EH. The role of patient care teams in chronic disease management. BMJ. 2000;320(7234):569–572.
   PubMedGoogle Scholar
• Services CfMMHospital Readmissions Reduction Program (HRRP). 2019. https://www.cms.gov/medicare/medicare-fee-for-service-payment/acuteinpatientpps/readmissions-reduction-program.html. Accessed Fuly 19, 2019.
   Google Scholar
• Hsu DJ, McCarthy EP, Stevens JP, Mukamal KJ. Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001–12. Addiction. 2017;112(9):1558–1564.
   PubMed Web of Science ®Google Scholar